CT News and Research

RSS

FDA categorizes Cepheid's Xpert CT/NG test as 'Moderate Complexity' under CLIA

Cepheid today announced the U.S. Food & Drug Administration (FDA) has categorized Cepheid's Xpert CT/NG test as 'Moderate Complexity' under the Clinical Laboratory Improvement Amendments (CLIA).

17 Jan 2013

FDA approves InfraScan’s noninvasive handheld brain hematoma detector

InfraScan, a medical device company specializing in brain injury diagnostic products, announced today that it has obtained U.S. Food and Drug Administration approval to market the Infrascanner Model 2000, a noninvasive handheld brain hematoma detector.

17 Jan 2013

SPECT-CT improves preop foot diagnosis

Research demonstrates the usefulness of radionuclide bone scans with single photon-emission computed tomography and computed tomography for the assessment of patients awaiting foot or angle surgery.

16 Jan 2013

Aggressive surveillance questionable for eye melanoma recurrence

Patients treated for primary choroidal or ciliary body melanoma may not always benefit from an aggressive surveillance strategy for the detection of metastatic disease, caution US researchers.

14 Jan 2013

Study reports on development and testing of Hematuria Risk Index to predict cancer risk

Microscopic amounts of blood in urine have been considered a risk factor for urinary tract malignant tumors. However, only a small proportion of patients referred for investigation are subsequently found to have cancer. A new Kaiser Permanente Southern California study published in the February Mayo Clinic Proceedings reports on the development and testing of a Hematuria Risk Index to predict cancer risk.

10 Jan 2013

CTI initiates enrollment in pacritinib Phase 3 trial for myelofibrosis

Cell Therapeutics, Inc. (CTI) today announced that the Company has initiated clinical trial sites and began enrolling patients in a Phase 3 clinical trial, known as PERSIST-1 or PAC325, for pacritinib, CTI's investigational JAK2 inhibitor, which is being evaluated for the treatment of patients with myelofibrosis.

9 Jan 2013

USC’s Keck Medical Center installs Aplio 500 and Viamo ultrasound systems from Toshiba

To stay competitive using the most cutting-edge technology, the Keck Medical Center of the University of Southern California (USC) installed two Aplio 500 ultrasound systems and a Viamo ultrasound system from Toshiba America Medical Systems, Inc. at its Keck Hospital of USC in Los Angeles, Calif.

9 Jan 2013

Study questions need for routine repeated CT scans in patients with mild head trauma

When initial computed tomography (CT) scans show bleeding within the brain after mild head injury, decisions about repeated CT scans should be based on the patient's neurological condition, according to a report in the January issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

4 Jan 2013

Roundup: Ill. to scrutinize Medicaid eligibility; 20% of Fla. nursing homes on 'watch' list; Conn.'s 'inadequate' mental health care system

Fort Pierce resident Cathi Odom recently learned that her mother's nursing home is one of 140 on the state's "Watch List." Families for Better Care, a citizen advocacy organization, found that one in five facilities in Florida are on that list for not meeting state standards, or for not making corrections quickly enough. Twelve of the homes have been on the watch list for more than 100 days. Brian Lee, executive director for Families for Better Care, says that is unacceptable.

4 Jan 2013

FDA clears Soft Tissue Regeneration’s STR GRAFT

Soft Tissue Regeneration, an early stage orthopedic device company that has developed a breakthrough tissue engineering platform used to regenerate ligaments and tendons, announced today that it has received FDA clearance to market its STR GRAFT, a biodegradable scaffold used for soft tissue augmentation and rotator cuff repair.

3 Jan 2013

18F-FDG PET/CT may become important distant staging modality in patients with breast cancer

New research published in the January issue of The Journal of Nuclear Medicine shows that 18F-fludeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography (CT) imaging offers significant prognostic stratification information at initial staging for patients with locally advanced breast cancer. When compared to conventional imaging, 18F-FDG PET/CT more accurately showed lesions in the chest, abdomen and bones in a single session, changing management for more than 50 percent of the patients in the study.

3 Jan 2013

New analysis on global trends in medical imaging for cardiology applications

The promise of cost and clinical benefits are spurring the penetration of imaging modalities in cardiac applications. While demographics are favouring market growth, cardiac imaging device manufacturers will have to focus on innovative, patient-friendly products that promote greater safety and easier operability.

2 Jan 2013

New insights into devastating second impact syndrome

Physicians at Indiana University School of Medicine and the Northwest Radiology Network (Indianapolis, Indiana) report the case of a 17-year-old high school football player with second impact syndrome (SIS). A rare and devastating traumatic brain injury, SIS occurs when a person, most often a teenager, sustains a second head injury before recovery from an earlier head injury is complete.

2 Jan 2013

Routine reimaging unnecessary after mild head injury

Scheduling a repeat computed tomography scan for patients with mild traumatic brain injury and stable neurologic signs is unnecessary, given that it rarely changes management, say Canadian researchers.

28 Dec 2012

Structure, training support reliable telestroke service

Clinically relevant misinterpretation of computed tomography images via telemedicine is rare in a system that uses a structured assessment of images, say German researchers.

28 Dec 2012

FDA clears Cepheid Xpert CT/NG molecular diagnostic test

Cepheid today announced that it has received clearance from the U.S. Food & Drug Administration to market Xpert CT/NG. Running on Cepheid's GeneXpert Systems, Xpert CT/NG is a qualitative in vitro molecular diagnostic test for the detection and differentiation of Chlamydia trachomatis and Neisseria gonorrhoeae. For the first time, same-day patient consultation and treatment is possible for the two most common sexually transmitted bacterial infections in the United States.

28 Dec 2012

Study on prevalence of coronary atherosclerosis among U.S. soldiers

Among deployed U.S. service members who died of combat or unintentional injuries between 2001-2011 and underwent autopsies, the prevalence of coronary atherosclerosis was 8.5 percent, with factors associated with a higher prevalence of the disease including older age, lower educational level and prior diagnoses of dyslipidemia, hypertension, and obesity, according to a study in the December 26 issue of JAMA.

26 Dec 2012